The QualityStocks Daily Wednesday, January 7th, 2026

Today's Top 3 Investment Newsletters

MarketClub Analysis(CAVR) $0.0005 +66.67%

QualityStocks(NBY) $10.6400 +43.98%

Market Munchies(VTYX) $13.7300 +36.62%

The QualityStocks Daily Stock List

NovaBay Pharmaceuticals (NBY)

RedChip, QualityStocks, IRGnews Alert, StockMarketWatch, BUYINS.NET, Wall Street Resources, MarketClub Analysis, StreetInsider, SmallCapVoice, MarketBeat, StockWireNews, Small Cap Firm, Fierce Analyst, InvestorPlace, SmarTrend Newsletters, ProTrading Research , PennyStockProphet, Wall Street Corner, TopPennyStockMovers, The Street, Investing Futures, HotOTC, Buzz Stocks, ChartPoppers, CRWEFinance, OTCPicks, FreeRealTime, BullRally, MadPennyStocks, CoolPennyStocks, PoliticsAndMyPortfolio, Marketbeat.com, BestOtc, Money Morning, Investopedia, SECFilings.com News, Wall Street Reporter, Trades Of The Day, TradersPro, Street Insider, StockStreetWire, StockRich, StockOnion, StockMister, PennyStockVille, SecretStockPromo, OTCtipReporter, Promotion Stock Secrets, Premium Stock Alerts, WealthMakers, Planet Penny Stocks, AllPennyStocks, PennyOmega, PennyInvest, Penny Pick Finders and StockEgg reported earlier on NovaBay Pharmaceuticals (NBY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NovaBay Pharmaceuticals Inc. (NYSE American: NBY) (FRA: B9PA) is a medical device firm that is focused on the development of products for the eye care markets internationally as well as in the U.S.

The firm has its headquarters in Emergyville, California and was founded in 2000, on January 19th by Ramin Najafi. Prior to its name change in February 2007, the firm was known as NovaCal Pharmaceuticals Inc. It operates in the consumer discretionary sector, under the wholesale-discretionary sub-industry.

The company centers mainly on commercializing prescription Avenova, which is one of its products that’s indicated for the management of hygiene of the lashes and eyelids in the U.S. It provides CelleRx Clinical Reset and Avenova through its online sales channels and sells its products via distribution partners.

The enterprise provides PhaseOne and NeutroPhase, which are indicated for the wound care market; a gentle and soothing facial spray dubbed CelleRx Clinical Reset and a solution developed for cleansing and removing foreign materials like debris and microorganisms from skin surrounding the eye, including the eyelids, dubbed Avenova. The enterprise also provides KN95 masks and has also developed a 2nd category of new compounds that harness the power of white blood cell chemistry. This category is made up of auriclosene; a synthetic and patented molecule that can help fight fungi, viruses and bacteria.

NovaBay Pharmaceuticals (NBY), closed Wednesday's trading session at $10.64, up 43.9783%, on 3,372,011 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $0.3041/$11.1391.

Voip-Pal.Com Inc. (VPLM)

QualityStocks, Equities.com, MarketClub Analysis, Pumps and Dumps, Mega Stock Pick, Stock Rich, HotOTC, Pick Alerts, equities Canada, CoolPennyStocks, Clutch Investments, Monster OTC, Buzz Stocks, Penny Stock Fever, BullRally, Google Alerts, StockEgg, MajorPennyStocks, Breaking Bulls, Bullish Stock Picks, Wallstreetbuzz, Bullseyestox.com, VC Stock Marketing, UndiscoveredEquities, TryBestPennyStocks.biz, TooNiceStocks, TheSUBWAY, FeedBlitz, Stockoutlaws, Penny Invest, HotStockProfits, SmallCapAllStars, Stock Twiter, Mega Stock Picks, Stock Traders Chat, NYC Marketing Inc, Best Stock Picks, Stock Fortune Teller, WallstreetsHotteststocks, Premiumstockpicks, Promotion Stock Secrets, SmallCapVoice and StockHotTips reported earlier on Voip-Pal.Com Inc. (VPLM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Voip-Pal.Com Inc. (OTCQB: VPLM) is a broadband VoIP telecom firm which develops and owns a portfolio of VoIP services.

The firm has its headquarters in Waco, Texas and was incorporated in September 1997 by Emil Malak and Francis Assif. Prior to its name change in September 2006, the firm was known as VOIP MDI.com. It operates as part of the telecom services industry, under the communication services sector. The firm serves commercial and residential clients around the globe.

The company is focused on creating virtual bridges which span international communications. Its objective is to connect the world through the delivery of cost-efficient technology that enables high-volume voice, text and digital multi-media communications.

The enterprise provides routing and classification of communications geographically distributed nodes and over a number of networks; uninterrupted transmissions in the course of endpoint changes; mobile gateways; improved emergency calling support services; lawful interception of such communications; and billing and metering, including the resale of white label telecommunication services. It also offers a transactional billing platform that’s tailored to the air mile and points business. This is in addition to providing antivirus applications for smartphones. The enterprise serves wholesale and retail carriers, network suppliers and telephony system vendors.

The firm is focused on monetizing its VoIP (Voice over Internet Protocol) technology, which will help bring in revenues into the firm as well as attract additional investors. This is in addition to extending the firm’s consumer reach and global reach, which will bolster its growth and create revenue for its shareholders.

Voip-Pal.Com Inc. (VPLM), closed Wednesday's trading session at $0.0124, up 29.979%, on 8,722,144 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $0.0052/$0.025.

Serina Therapeutics (SER)

Streetwise Reports, QualityStocks, Fierce Analyst and 360 Wall Street reported earlier on Serina Therapeutics (SER), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Serina Therapeutics Inc. (NYSE American: SER) (FRA: 2BO) is a biotechnology firm focused on the development of drugs for the treatment of neurological illnesses and pain.

The firm has its headquarters in Huntsville, Alabama and was incorporated in 2024, on March 26th by Michael D. Bentey and J. Milton Harris. Prior to its name change, the firm was known as AgeX Therapeutics Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm primarily serves consumers in the United States.

The company develops polymer technology, which has been designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. Its POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. Its POZ Platform partners are at the forefront in advancing LNP delivery technology to develop RNA therapeutics.

The enterprise’s lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. It also develops SER 214 for the treatment of Parkinson's disease; SER 228 to treat epilepsy; and SER 227 for long-acting pain relief. In addition to this, the enterprise develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious illnesses.

Serina Therapeutics (SER), closed Wednesday's trading session at $2.42, up 16.3462%, on 904,210 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $1.7101/$7.92.

Armata Pharmaceuticals (ARMP)

QualityStocks, TradersPro, FreeRealTime, StockMarketWatch and MarketBeat reported earlier on Armata Pharmaceuticals (ARMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Armata Pharmaceuticals Inc. (NYSE American: ARMP) (FRA: TG1N) is a biotechnology firm that is engaged in developing targeted bacteriophage therapeutics for treating antibiotic-resistant infections across the globe.

The firm has its headquarters in Marina del Rey, California and was incorporated in 2019, on May 9th. It operates as part of the pharmaceutical industry, under the health care sector, in the biotech and pharma sub-industry and mainly serves consumers in the state of California.

The company is focused on improving human health by developing new synthetic and natural bacteriophage-based treatments using 2 platforms, namely peptides and synthetic phages, which will help prevent infectious ailments of the microbiome and treating multidrug-resistant bacterial infections. It is party to a partnership agreement with Merck & Co. which entails the development of synthetic phage candidates that target infectious disease agents. The company was formed as a result of a merger between AmpliPhi Biosciences and C3J Therapeutics.

The enterprise’s product pipeline comprises of AP-PA03, which is indicated for the treatment of pneumonia; AP-PA02, which has been developed to treat Pseudomonas aeruginosa and AP-SA02, which is indicated for the treatment of Staphylococcus aureus bacteremia. Each of the enterprise’s product candidates is a combination of several chosen phages, which target a particular disease-causing bacterial pathogen.

Armata Pharmaceuticals (ARMP), closed Wednesday's trading session at $6.68, up 13.799%, on 33,421 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.8981/$16.34.

Lynas Corporation Limited (LYSCF)

SmarTrend Newsletters, Jason Bond, MarketBeat, London Irvine Report, QualityStocks, TradersPro, Leeb's Market Forecast, PennyStockPower, The Bull Report, BullRally, CoolPennyStocks, HotOTC, Investment U, InvestorPlace, PennyInvest, Top Pros' Top Picks, Smart Penny Stocks, MadPennyStocks, AllPennyStocks, StockRich, Wall Street Wolves, PennyStockVille, StockEgg and Wall Street Elite reported earlier on Lynas Corporation Limited (LYSCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lynas Corporation Limited is a rare earths producer based in Malaysia. The Company, together with its subsidiaries, engages in the exploration, development, mining, extraction, and processing of rare earth minerals mainly in Australia and Malaysia. Rare earths are a group of chemical elements with unique magnetic, luminescent, and electrochemical properties. Lynas is an integrated source of rare earths from mine to customer. The Company lists on the OTC Markets.

Lynas is the world's only major producer of rare earth minerals outside of China. The materials it produces, such as neodymium-praseodymium, are used in an array of applications including electrical components and high-power magnets.

Lynas has a portfolio of aligned assets to explore, develop, mine and process rare earth minerals. These assets include Mt Weld – one of the world's highest grade rare earths mines, located 35km south of Laverton in Western Australia; and the Mt Weld Concentration Plant – commissioned in 2011 and located 1.5km from the mine site.

Assets also include the Lynas Advanced Materials Plant (LAMP). This is an integrated manufacturing facility, separating and processing rare earths materials, located in the Gebeng Industrial Estate (GIE) near the Port of Kuantan in Malaysia.

Lynas Corporation Limited (LYSCF), closed Wednesday's trading session at $10.2405, up 12.2247%, on 85,647 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $3.8/$16.2.

Western Uranium & Vanadium Corp. (WSTRF)

QualityStocks, TradersPro, InvestorIntel, Investor News and Trades Of The Day reported earlier on Western Uranium & Vanadium Corp. (WSTRF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Western Uranium & Vanadium Corp. is a uranium and vanadium conventional mining company. It focuses on low cost near-term production of uranium and vanadium in the western United States, and also the development and application of ablation mining technology. Ablation Mining Technology (AMT) is a proprietary process that improves efficiency and lessens costs for sandstone hosted deposits. Western Uranium & Vanadium has offices in Toronto, Ontario and Nucla, Colorado. The Company lists on the OTCQX.

Western Uranium & Vanadium is among the largest U.S. Uranium and Vanadium in-situ resource holders. It has a total uranium resource of 70,000,000 lbs. +/- and a total vanadium resource of 35,000,000 lbs. +/- grading between 1.4-2.2 percent. Its near-term production strategy includes focusing on previously producing mines for low capex (capital expenditures), existing infrastructure, and permitting.

The Company’s strategy also includes defining and developing a high-grade vanadium resource at the Sunday Mine Complex (SMC). Furthermore, its strategy is to deliver SMC ore samples to numerous potential customers and joint venture (JV) partners, and baseload SMC production with a vanadium ore concentrate agreement.

Moreover, Western Uranium & Vanadium’s strategy is to pursue vanadium development at the Sage Mine Project. It will also work to pursue uranium contracts and development at prices above current price levels.

Western Uranium & Vanadium Corp. (WSTRF), closed Wednesday's trading session at $0.5102, up 10.913%, on 197,480 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.32/$1.

American Lithium Corp. (AMLIF)

InvestorPlace, The Night Owl, QualityStocks, On Options, iDigital Market, DividendStocks and bullseyeoptiontrading reported earlier on American Lithium Corp. (AMLIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Lithium Corp. (OTCQX: AMLIF) engages in the identification, acquisition, exploration for, and development of lithium deposits in the Americas. An exploration stage company, it is exploring and developing the TLC Project situated in the highly prospective Esmeralda lithium district in Nevada. The Company formerly went by the name Menika Mining Ltd. It changed its name to American Lithium Corp. in April of 2016. Incorporated in 1974, American Lithium is based in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

The TLC Project is close to infrastructure, 3.5 hours south of the Tesla Gigafactory. It is in the same basinal environment as Albemarle's Silver Peak lithium mine and several advancing deposits and resources. These include Ioneer Ltd.'s (formerly Global Geoscience) Rhyolite Ridge and Cypress Development Corp.'s Clayton Valley project.

Currently, American Lithium holds a considerable land position consisting of greater than 4,000 acres at its TLC Project near Tonopah, Nevada, one of the most promising and underdeveloped lithium sedimentary basins in North America. Its recent drill program produced core samples up to 2,285 ppm lithium with many samples more than 1,000 ppm lithium.

American Lithium Corp. (AMLIF), closed Wednesday's trading session at $0.6345, up 10.6943%, on 429,070 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $0.21/$0.9119.

Planet 13 Holdings, Inc. (PLNH)

We reported earlier on Planet 13 Holdings, Inc. (PLNH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Planet 13 Holdings, Inc. is a foremost vertically-integrated Nevada cannabis company listed on the OTC Markets’ OTCQB. The Company has award-winning cultivation, production and dispensary operations in Las Vegas, Nevada. Planet 13’s emphasis is on providing a premier dispensary experience and optimizing cultivation efficiencies via its best-in-class technology, as the vanguard of cannabis. Planet 13 Holdings is headquartered in Las Vegas.

On November 1, 2018, Planet 13 opened the largest, most advanced retail dispensary worldwide immediately next to the Las Vegas strip. The Company has greater than six Cannabis Licenses and is fully licensed for cultivation, retail distribution and more in the fast growing Nevada market.

Planet 13 offers first-rate quality recreational cannabis, cannabis extracts, as well as infused products. Its brands include Planet 13 Las Vegas, Medizin, and TRENDI. Medizin provides a quality assortment of award-winning products. Medizin grows medicinal marijuana and all Medizin plant genetics are hand-selected. TRENDI specializes in expertly crafted cannabis products that create the trend. TRENDI employs leading edge technology and an innovative visual approach to deliver a premier product.

Planet 13 Holdings, Inc. (PLNH), closed Wednesday's trading session at $0.2083, up 10.2116%, on 556,267 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.148/$0.5.

AIRO Group Holdings Inc. (AIRO)

SmallCapVoice, MarketBeat, Earnings360 and Early Bird reported earlier on AIRO Group Holdings Inc. (AIRO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AIRO Group Holdings Inc. (NASDAQ: AIRO) is an advanced aerospace and defense firm.

The firm has its headquarters in Albuquerque, New Mexico and was incorporated in 2021, on August 30th by Chirinjeev Kathuria. It operates as part of the aerospace and defense industry, under the industrials sector. The company mainly serves consumers in the United States.

AIRO Group operates through the Avionics and Electronics; Drones; Training; and Electric Air Mobility segments. The Avionics and Electronics segment develops, manufactures, and sells critical navigation and communication avionics for military and general aviation aircraft, drones, and electric vertical take-off and landing (eVTOL). This segment offers flight displays, connected panels, and GPS/GNSS sensors. Its Drones segment develops, manufactures, and sells drones, performing crucial missions such as Intelligence, Surveillance, and Reconnaissance (ISR) and target tracking, mapping, surveying, inspection, and localization, thus enhancing military and commercial operational efficiency globally.

On the other hand, the Training segment delivers specialized professional training services to the commercial aviation and military communities, including adversary air, close air support, ground liaison services, ISR, aircraft leasing, pilot training, and Joint Terminal Attack Controller (JTAC). It also offers joint theater ISR and simulated ground strike training and consulting services. Further, its Electric Air Mobility segment develops an eVTOL rotorcraft for cargo and passengers, thus transforming urban transportation. AIRO Group’s manufacturing facility is located in Phoenix, Arizona.

The company recently announced the successful completion of the first RQ‑35 ISR drones produced to full operational standard in its U.S. manufacturing facility. This is a major step forward in the firm’s expansion strategy and may positively influences its revenues as well as investments into the company. This is in addition to generating additional value for AIRO Group shareholders.

AIRO Group Holdings Inc. (AIRO), closed Wednesday's trading session at $10.74, off by 3.6771%, on 1,191,318 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $7.28/$39.07.

Canopy Growth Corp. (CGC)

InvestorPlace, Schaeffer's, The Street, QualityStocks, StocksEarning, StockEarnings, MarketClub Analysis, Trades Of The Day, MarketBeat, Daily Trade Alert, Kiplinger Today, The Online Investor, Wealth Insider Alert, Streetwise Reports, StreetInsider, CFN Media Group, Market Intelligence Center Alert, Investopedia, Zacks, CannabisNewsWire, StreetAuthority Daily, Stock Up Featured, The Wealth Report, Early Bird, Daily Profit, Top Pros' Top Picks, SmallCapVoice, SeriousTraders, Lebed.biz, Wall Street Grand, StockMarketWatch, INO Market Report, Profit Trends, Money Morning, Louis Navellier, BUYINS.NET, Cannabis Financial Network News, Jim Cramer, CNBC Breaking News, Inside Trading, Investors Underground, MarketClub, Outsider Club, Trading For Keeps, StocksToBuyNow, TradersPro, Market Munchies, Insider Wealth Advice, AllPennyStocks, Beat The Street, Wealth Daily, Cabot Wealth, VectorVest, Trading Concepts, Timothy Sykes, Tim Bohen, TheTradingReport, Profit Confidential, Technology Profits Daily, Investment U, InvestmentHouse, Stock Gumshoe, Investors Alley, Rick Saddler, Raging Bull All Access, 24/7 Trader, Money and Markets and The Markets Daily reported earlier on Canopy Growth Corp. (CGC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Florida’s debate over recreational cannabis is resurfacing after a failed ballot initiative and renewed public support, setting the stage for a possible return to voters in 2026. 

During the 2024 election cycle, a proposed constitutional amendment to legalize adult-use marijuana earned backing from 56% of voters. While that represented a clear majority, it did not meet the state’s 60% threshold required to amend the constitution. As a result, recreational marijuana remained illegal despite growing public approval. 

New polling suggests attitudes have continued to shift. A survey conducted by the University of North Florida in 2025 found that support for recreational cannabis had climbed to 66%, well above the level needed to pass if voters were asked again. Advocates argue that the earlier defeat reflected concerns about the details of the proposal rather than outright opposition to legalization. 

Governor Ron DeSantis was a vocal critic of the 2024 measure and played a prominent role in the public debate. At the time, he warned that legalization would lead to widespread use and change the character of public spaces, arguing the amendment went far beyond easing penalties. 

The earlier proposal allowed adults to purchase cannabis only from state-approved retailers and did not permit people to grow plants at home. Critics raised alarms about potential advertising aimed at minors, while some supporters felt the plan was too restrictive and favored personal cultivation rights. 

The revised version explicitly allows limited home cultivation, prohibits smoking or vaping cannabis in public areas, and bans any form of marketing directed at children. 

Florida’s GOP chair Joe Gruters, a supporter of legalization, said allowing residents to grow their own marijuana does not undermine the regulated market. He noted that in states where recreational use is legal, personal cultivation tends to exist alongside licensed dispensaries rather than replace them. 

Throughout 2025, sponsors have focused on gathering signatures to move the proposal forward. To qualify for review, they must submit over 880,000 valid signatures by February 1. The campaign had turned in over 675,000 by December 2025. However, roughly 200,000 were rejected because they did not include the full text of the amendment, forcing organizers to continue collecting petitions. 

If the campaign reaches the required number and the Florida Supreme Court signs off on the language, the measure could appear on the 2026 ballot. Voter approval would significantly reshape Florida’s marijuana laws, with implications for consumers, businesses, law enforcement, and the use of public spaces across the state. 

The reform movement, as well as notable industry firms like Canopy Growth Corp. (NASDAQ: CGC) (TSX: WEED), will be hoping that the outcome of the ballot measure reflects the true will of the state residents. 

Canopy Growth Corp. (CGC), closed Wednesday's trading session at $1.19, up 0.8474576%, on 12,687,965 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $0.77/$2.9.

Scinai Immunotherapeutics Ltd. (SCNI)

SmallCapRelations, BioMedWire, QualityStocks, SeriousTraders, InvestorBrandNetwork, MissionIR, Tiny Gems, Stocks to Buy Now, StocksToBuyNow, Tip.us, SmallCapSociety, NetworkNewsWire, MarketClub Analysis, 360 Wall Street, Premium Stock Alerts and Schaeffer's reported earlier on Scinai Immunotherapeutics Ltd. (SCNI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Scinai Immunotherapeutics (NASDAQ: SCNI) announced that Chief Executive Officer Amir Reichman will co-lead a Manufacturers Association of Israel–organized roundtable discussion titled “Biopharma Manufacturing in Israel: Capabilities, Gaps, and Scale” during HealthIL Week 2026. The session, scheduled for Jan. 19, 2026, at Expo Tel Aviv, will focus on Israel’s biopharma development and manufacturing ecosystem, including early-stage development, CMC activities, and clinical manufacturing, as well as readiness for later-stage and commercial manufacturing. The roundtable is expected to bring together representatives from government agencies, biopharma manufacturers, CDMOs, multinational pharmaceutical companies, biotech firms, and investors to examine current capabilities, structural gaps, and collaboration models shaping the sector’s future.

To view the full press release, visit https://ibn.fm/dfb1F

About Scinai Immunotherapeutics

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biopharmaceutical company with two complementary business units:

  • Scinai Bioservices, a boutique CDMO providing analytical method development, process development, and clinical cGMP manufacturing services for biotech clients worldwide.
  • Scinai R&D, focused on developing innovative I&I therapeutics based on NanoAbs (VHH antibody fragments) with unique physicochemical properties suitable for advanced mono- and multi-specific antibody formats.

Scinai Immunotherapeutics Ltd. (SCNI), closed Wednesday's trading session at $0.8, off by 3.218%, on 7,803 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $0.613/$6.18.

Estrella Immunopharma (ESLA)

QualityStocks and MarketBeat reported earlier on Estrella Immunopharma (ESLA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Estrella Immunopharma (NASDAQ: ESLA, ESLAW) announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor, generating aggregate gross proceeds of approximately $8.0 million. The offering included the issuance of 4,063,290 shares of common stock and 1,000,000 pre-funded warrants, together with a concurrent private placement of common warrants to purchase up to 7,594,935 additional shares, with net proceeds expected to be used for general corporate purposes and working capital as the company advances its CD19 and CD22-targeted ARTEMIS T-cell therapy programs, including lead candidate EB103. Aegis Capital Corp. acted as exclusive placement agent for the offerings.

To view the full press release, visit https://ibn.fm/rh6n9

About Estrella Immunopharma, Inc.

Estrella is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases. Estrella’s mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and other diseases. To accomplish this mission, Estrella’s lead product candidate, EB103, utilizes Eureka’s ARTEMIS technology to target CD19, a protein expressed on the surface of almost all B-cell leukemias and lymphomas. Estrella is also developing EB104, which also utilizes Eureka’s ARTEMIS technology to target not only CD19, but also CD22, a protein that, like CD19, is expressed on the surface of most B-cell malignancies.

For more information, please visit https://www.estrellabio.com/

Estrella Immunopharma (ESLA), closed Wednesday's trading session at $1.44, up 5.1095%, on 54,431 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $0.7301/$3.15.

The QualityStocks Company Corner

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ)

The QualityStocks Daily Newsletter would like to spotlight A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, announced it will participate in CES 2026 as a sponsor of the CES Foundry, a two-day event at the Fontainebleau Las Vegas, January 7 and 8, 2026. At the event, D-Wave will showcase its award-winning annealing quantum computing technology, hybrid quantum-classical solvers, and real-world customer use cases that are demonstrating measurable performance benefits, often beyond classical computing alone. Murray Thom, vice president of quantum technology evangelism at D-Wave, will present a masterclass and demo on Wednesday, January 7 from 1 p.m. to 1:30 p.m. PT, educating attendees about how to realize value from quantum computing today. Register for the masterclass here: https://www.ces.tech/schedule/how-quantum-computing-is-transforming-business-today/

"Showcasing quantum computing at CES, one of the world's most influential technology stages, signals that the technology is quickly moving into the mainstream," said Murray Thom. "D-Wave is uniquely positioned to demonstrate practical quantum in action, and we're excited to show how our systems are helping customers solve complex problems now, often with greater speed, efficiency, and impact than classical computing alone."

To view the full press release, visit https://ibn.fm/i3JYB

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) is a global retail technology company focused on redefining how consumers and retailers interact in physical store environments. Through its innovative smart cart platform, the company offers a powerful vehicle for in-store digital engagement and monetization. A2Z’s business model blends hardware, software, retail media and data services to deliver scalable, recurring revenue across multiple layers of the retail value chain.

With a clear vision to unlock the full potential of every in-store shopping journey, A2Z is committed to bridging the gap between digital convenience and physical retail. Its mission centers on transforming routine trips into dynamic experiences that benefit both shoppers and retailers by enhancing satisfaction, loyalty, and operational performance. The company’s growth is supported by strategic deployments, long-term commercial agreements, and a global footprint spanning four continents.

A2Z Cust2Mate is headquartered in Canada, Israel and the United States.

Products

A2Z Cust2Mate’s flagship offering is its smart shopping cart platform, designed to bring the benefits of e-commerce into the brick-and-mortar environment. The Cust2Mate smart cart allows shoppers to scan products, receive personalized offers, and pay directly through the cart—bypassing traditional checkout lines entirely. The system integrates real-time product search, allergen warnings, nutritional data, and location-based promotions, creating a frictionless and engaging shopping experience.

For retailers, the smart cart addresses key pain points such as theft reduction, labor optimization, and shopper engagement at the point of purchase. It provides actionable, data-driven insights that improve operational efficiency and merchandising strategies. Recent commercial results have shown increases of over 15% in purchases per shopper, strong satisfaction ratings, and 75% customer return rates. The platform also supports queue management, loyalty integration, and screen-based advertising, with the ability to retrofit legacy carts using detachable modular control panels.

The company’s operations follow a hybrid revenue model including outright purchases, SaaS-based subscriptions, and recurring fees tied to software, support, and media monetization. Carts are manufactured through Tier 1 contract manufacturers, and scalable financing solutions are in place to support ongoing growth.

In October 2025, the company launched an AI and Business Insights Division to advance artificial intelligence integration across its smart-cart ecosystem. The initiative focuses on generative-AI-powered personalization, retail-media targeting, fraud detection, product recognition, and store optimization, further strengthening A2Z Cust2Mate’s leadership in data-driven retail innovation.

Market Opportunity

A2Z Cust2Mate operates in a rapidly expanding market for smart shopping cart solutions and in-store retail media. According to 360i Research, the global smart shopping cart market is forecast to grow from $2.2 billion in 2024 to $9.7 billion by 2030, representing a 27% CAGR. Simultaneously, the retail-media sector, driven by targeted, point-of-sale advertising, is projected to reach $165 billion by 2025, reflecting an approximate 20% compound annual growth rate.

The company’s monetization strategy is well-aligned with these trends. Under its 2025 agreement with Yochananof, A2Z Cust2Mate gained exclusive rights to monetize digital assets, retail media, and behavioral data generated by its deployed smart carts. Building on that foundation, the company secured multi-year retail-media agreements with Toys “R” Us Israel, The Red Pirate, and Lego, extending advertising campaigns across up to 5,000 smart carts. These partnerships combine cost-per-thousand (CPM) advertising with commission-based revenue on completed transactions, providing guaranteed recurring income and validating Cust2Mate’s model as a retail-media and data-monetization platform for global brands.

Additionally, A2Z aims to unlock new revenue streams through a digital cart marketplace, enabling sponsored product placements, third-party app integrations, and basket-based upsells. These capabilities extend the smart cart’s value proposition beyond hardware into data, advertising, and digital commerce, supporting the company’s long-term vision for platform-based growth.

Leadership Team

Bentsur Joseph, Chairman, is a serial entrepreneur with a strong track record in building and expanding successful corporations. He previously served as Chairman of Elad Hotels (part of the Tshuva Group, one of Israel’s largest conglomerates) and held a director position at MARLAZ, a public holding company involved in industrial, real estate, communication, and high-tech sectors. Earlier in his career, he was Operations Manager at Comfy Interactive Movies, a leading publicly traded edutainment company.

Gadi Graus, CEO, brings over 30 years of multidisciplinary business expertise and a proven track record of global leadership. He has deep corporate and commercial experience across international and cross-border practices, supporting high-tech, industrial, and manufacturing firms from startup to multinational levels.

Elkana Porag, Deputy CEO and CTO, has more than 30 years of experience in technology and strategic consulting. He has held senior roles in tech strategy, architecture, and CTO leadership across Fortune 500 companies, global enterprises, and startups. Known for delivering impactful results and navigating complex organizational dynamics, he is highly regarded for his ability to transform innovative technologies into competitive business solutions.

Alan Rootenberg, CFO and Director, is a Chartered Professional Accountant with significant experience as CFO of publicly traded companies on the TSX, TSX Venture Exchange, OTCBB, and CSE. His sector expertise spans mineral exploration, mining, technology, and cannabis. He holds a Bachelor of Commerce from the University of the Witwatersrand in Johannesburg, South Africa, and earned his CPA designation in Ontario, Canada.

Investment Considerations
  • The company completed an oversubscribed $45 million equity financing round anchored by global institutional investors, fully funding its strategic growth initiatives.
  • A2Z Cust2Mate is addressing a global smart cart market expected to grow at a 27% CAGR through 2030.
  • The company secured a $55 million order from leading Israeli retailer Yochananof in September 2025.
  • Retail media monetization is now a core revenue stream, supported by exclusive rights and growing CPM- and commission-based ad sales.
  • A2Z maintains a scalable, recurring-revenue model through SaaS, media, and analytics offerings.
  • With deployments across four continents and a $25 million+ Latin American order underway, A2Z is positioned for global expansion.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), closed Wednesday's trading session at $8.04, up 3.0769%, on 1,148,043 volume. The average volume for the last 3 months is 523,992 and the stock's 52-week low/high is $4.9975/$12.36.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

Wearable Devices (NASDAQ: WLDS) announced the upcoming release of its Mudra Link Android app, extending its AI-powered neural gesture control experience to Android users with full feature parity and highlighting the platform at CES 2026. The standalone Android app delivers complete Mudra functionality, including gesture customization, command mapping, and guided onboarding, eliminating the prior requirement for macOS or Windows PCs for initial setup. Wearable Devices said the Android release is designed to reduce friction and broaden adoption across mobile, desktop, and extended reality workflows, with demonstrations of the Mudra Link Android experience planned at CES 2026 in Las Vegas.

To view the full press release, visit https://ibn.fm/TpBiF

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (https://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Wednesday's trading session at $5.54, up 4.5283%, on 9,791 volume. The average volume for the last 3 months is 18,864 and the stock's 52-week low/high is $4.93/$114.

Recent News

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT)

Disseminated on behalf of Nevada Organic Phosphate Inc., may include paid advertisements.

The QualityStocks Daily Newsletter would like to spotlight LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT).

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

At the core of SPARC AI's platform is a complement of spatial, predictive, approximation and radial convolution algorithms collectively known as "SPARC"

Proprietary technology can be applied across a wide range of use cases, including drone navigation, infrastructure inspection, logistics planning and defense operations

Spatial computing is becoming a foundational element of wartime modernization

As today's militaries increasingly depend on data-driven decision-making, the ability to understand terrain, movement and spatial risk in real-time has become a strategic priority rather than a technical luxury. This shift toward spatial computing and predictive analytics is reshaping how defense organizations plan, operate and deploy autonomous systems, and it is also creating opportunities for companies, such as SPARC AI (CSE: SPAI) (OTCQB: SPAIF) , that are developing mathematically grounded location-intelligence tools. Specifically, SPARC AI is positioning its technology to support military and defense applications by applying advanced mathematical modeling to spatial risk assessment, an approach that aligns closely with emerging priorities outlined in recent defense and technology reports.

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) is a clinical-stage pharmaceutical company developing differentiated cancer therapies built around a novel biological target. Rather than introducing standalone treatments, the company is focused on advancing a first-in-class approach designed to enhance the effectiveness of established cancer therapies, addressing persistent challenges that continue to limit outcomes in oncology.

LIXTE’s work centers on improving how chemotherapy and immunotherapy perform in difficult-to-treat cancers with significant unmet medical need. By translating a distinct scientific concept into therapies that can be integrated into existing treatment frameworks, the company aims to expand the reach and impact of current standards of care without requiring wholesale changes to clinical practice.

Alongside internal development, LIXTE has pursued selective strategic actions that extend its capabilities beyond drug development, supporting its evolution into a platform-oriented oncology company spanning both pharmaceutical and technology-driven approaches.

The company is headquartered in Boca Raton, Florida.

Portfolio

LB-100 (PP2A Inhibitor Platform)

LIXTE’s lead clinical candidate, LB-100, is a proprietary small-molecule inhibitor of protein phosphatase 2A (PP2A) designed to enhance the activity of chemotherapy and immunotherapy. The compound has demonstrated a favorable safety profile in Phase 1 clinical trials and has been supported by more than 25 published preclinical and translational studies. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with limited treatment options.

Ongoing trials include combinations of LB-100 with immunotherapy in ovarian clear cell carcinoma and metastatic MSI-low colon cancer, as well as combination therapy with chemotherapy in advanced soft tissue sarcoma. These studies are being conducted in collaboration with leading academic cancer centers and industry partners, reflecting LIXTE’s emphasis on externally validated clinical execution.

Radiotherapy Platform Expansion (Liora Technologies)

In November 2025, LIXTE expanded beyond pharmaceuticals with the acquisition of Liora Technologies Europe Ltd., adding an electronically controlled proton therapy platform known as the LiGHT System. This acquisition established LIXTE’s entry into radiotherapy, complementing its drug development activities and creating optionality for future recurring revenue models tied to jointly operated treatment centers.

Market Opportunity

LIXTE is targeting cancers where existing therapies show limited durability due to resistance, toxicity constraints, or suboptimal patient response. Chemotherapy and immunotherapy are widely applicable across tumor types but remain constrained by these factors, creating an opportunity for approaches that improve efficacy without proportionally increasing toxicity.

The company’s clinical programs focus on ovarian clear cell carcinoma, metastatic colon cancer, and advanced soft tissue sarcoma, indications characterized by high unmet need and limited effective treatment options. Rather than reshaping oncology care, LIXTE is developing LB-100 to augment existing therapies, an approach that could support wider clinical use within established treatment pathways.

Leadership Team

Geordan Pursglove, Chairman, President and Chief Executive Officer, is an accomplished executive and entrepreneur with more than a decade of experience spanning mergers and acquisitions, capital markets, strategic growth initiatives, and operational leadership across both public and private companies. His background includes leadership roles across technology, logistics, customer experience, sports, and marketing, with a focus on scaling organizations, raising capital, and executing transformative strategies.

Bas van der Baan, Chief Scientific Officer, has more than 20 years of experience in biotechnology with a concentration in oncology and diagnostics. He previously served as Chief Clinical and Business Development Officer at Agendia, where he played a key role in initiating and executing clinical trials that supported the commercialization of precision molecular oncology diagnostics in both the U.S. and Europe.

Peter Stazzone, Chief Financial Officer, brings over two decades of financial management experience across publicly traded and privately held companies. His background includes leading capital raises, mergers and acquisitions, financial controls, and public company reporting, with prior CFO roles at companies including Beyond Commerce, Strainz, and Voice Telecom.

Investment Considerations
  • LIXTE is advancing a first-in-class PP2A inhibitor platform designed to enhance, rather than replace, established chemotherapy and immunotherapy regimens.
  • The company is conducting multiple active clinical trials in solid tumors with significant unmet medical need, supported by academic and industry collaborations.
  • LIXTE’s scientific strategy is protected by a comprehensive patent portfolio, with management noting no known direct competitors targeting PP2A inhibition.
  • Strategic actions in 2025, including the acquisition of Liora Technologies and a registered direct offering completed in December 2025, reflect an effort to broaden capabilities and strengthen operational flexibility.
  • Expansion of the ovarian clear cell carcinoma trial in December 2025, with plans to double patient enrollment and present initial findings in 2026, underscores continued clinical momentum.

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), closed Wednesday's trading session at $3.94, up 10.6742%, on 175,510 volume. The average volume for the last 3 months is 84,286 and the stock's 52-week low/high is $0.64/$6.26.

Recent News

BlockQuarry Corp. (OTC: BLQC)

The QualityStocks Daily Newsletter would like to spotlight BlockQuarry Corp. (OTC: BLQC).

BlockQuarry Corp. (OTC: BLQC), through its in-house initiatives and strategic partnerships, has invested in growing operations targeting the telehealth and cryptocurrency mining industries.

The company specializes in strategic brand development and early growth facilitation. Management maneuvers its proprietary companies through critical stages of market development, including conceptualization, go-to-market strategies, engineering, product integration and distribution efficiency.

Mission

The company’s core mission is to enhance these sectors by implementing innovative services and products that are ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources and innovative software to establish market-leading companies and partnerships, thereby ensuring success in their chosen industries.

Cryptocurrency Mining

The start of 2021 saw a massive resurgence in interest surrounding bitcoin and cryptocurrency mining. In mid-February, bitcoin prices hit an all-time high of greater than $57,000, and heightened demand for cryptocurrency mining power has played a key role in exacerbating a global shortage of semiconductors and computer components.

With a foothold in the cryptocurrency mining space, ISW Holdings has placed significant focus on expanding its position and capitalizing on this momentum. Recent highlights include:

  • February 9, 2021: The company announced that its revolutionary Pod5 Cryptocurrency Mining Pod will be powered up into full operational launch at the Bit5ive renewable energy cryptocurrency mining facility in Pennsylvania on February 12, 2021.
  • February 11, 2021: The company announced that it is in negotiations to purchase a large number of miners (between 300 and 900) in preparation for its coming Phase 3 expansion in mining volume.
  • February 23, 2021: The company announced its entry into a comprehensive Hosting and Maintenance Agreement prior to going online with its new ASIC s17 miners.
  • March 2, 2021: The company announced that it has successfully tripled its active cryptocurrency mining fleet with the addition of two new POD5IVE datacenters.

“As we continue to bring our miners online, we want our shareholders to be able to track the expansion and profitability of the company’s mining activity given the sharp rising trend in bitcoin prices,” Alonzo Pierce, President and Chairman of ISW Holdings, stated in a news release. “It currently costs about $11K in computing power to mine a single bitcoin. Bitcoin is pricing at over five times that level, making this is an exceptional ROI opportunity, and our responsibility to our shareholders is clear: continue to invest, expand and execute.”

Business Innovations

ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. Some of the company’s current holdings and partnerships include:

  • Bit5ive LLC: ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.
  • Proceso LLC: ISW Holdings has partnered with Proceso LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining.
  • PHH Health: The company’s home health division answers the growing need for home care services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care.
  • Volum: The company’s logistics and supply chain management division is designed with the core goal of increasing supply chain efficiency, which is recognized as one of the key aspects of successfully growing any business.

Market Opportunity

ISW Holdings’ recent activity in the cryptocurrency mining sector has positioned it to capitalize on the forecast expansion of the cryptocurrency market in the coming years. According to data from MarketsandMarkets, the cryptocurrency space was valued at $1.03 billion in 2019 and is projected to reach $1.40 billion in 2024, achieving a CAGR of 6.18% during the forecast period.

The report suggests that major drivers for this growth will be the transparency of the underlying blockchain technology, the high volume of remittances in developing countries, the high cost of international remittance, expected fluctuations in monetary regulations and sustained investment in the cryptocurrency space by venture capital firms.

Management Team

Terry Williams is the Chief Executive Officer and Director of ISW Holdings. Mr. Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, he amassed considerable corporate experience at UPS (NYSE: UPS), where he took several logistical roles, managing more than 2,000 employees and a budget of more than $10 billion. Mr. Williams also serves as president of Airware Transportation and Logistics and Chief Financial Officer of AVI Insurance Caribbean. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce is the company’s President and Chairman. He brings a wealth of business development and wealth management experience to the ISW team, having spent the past 20 years building recognizable brands in multiple industry sectors. Mr. Pierce has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown is Secretary, Treasurer and Director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Ms. Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

BlockQuarry Corp. (BLQC), closed Wednesday's trading session at $0.0193, up 14.2012%, on 1,143,099 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.00715/$0.0694.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

Massimo Group (NASDAQ: MAMO) announced it will exhibit at AIM Expo, North America's premier powersports industry event, where the company plans to showcase its 2026 product lineup and engage with existing and prospective dealer partners. At the show, Massimo is expected to feature its 2026 Sentinel Series fully enclosed HVAC UTVs and its MVR HVAC Pro Series electric carts, highlighting the company's expansion into higher-value, feature-rich platforms designed for consumer, commercial, fleet, municipal, security, and recreational applications. Management said the new platforms have generated strong early market feedback and pre-order interest, and the company will also present new 2026 dealer programs focused on improving dealer profitability through enhanced parts and service support, demo unit initiatives, and Sentinel Series rebate and incentive structures.

To view the full press release, visit https://ibn.fm/GGSfm

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Wednesday's trading session at $30.2, off by 3.4218%, on 36,716,216 volume. The average volume for the last 3 months is 35,526,300 and the stock's 52-week low/high is $3.74/$46.75.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB).

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising.

LaFleur Minerals Inc., a Canadian near-term gold producer, just closed its upsized, fully subscribed LIFE offering and FT offering, raising gross proceeds of over $6.9 million, funding the restart of its key asset the Beacon Gold Mill.

The company is moving quickly to capitalize on its unique processing opportunities offered by its Beacon Gold Mill, and the overall strength of the gold market.

LaFleur now anticipates 2026 as an especially significant year, both for the company's shareholders and for firmly establishing LaFleur's position as the newest gold producer in Canada's Abitibi belt.

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) , a Canadian gold exploration and development company has reached a pivotal milestone after closing a significant financing intended to fund the restart of its gold mill. With these funds, LaFleur will further advance its district-scale Swanson Gold Project in Québec's prolific Abitibi Gold Belt and progress towards the near-term restart of gold production at its wholly owned Beacon Gold Mill, remaining bullish about the gold market, and the company's standing compared to its peers. Just last month, the company announced an upsizing of its investment opportunity due to high demand for the offering, allowing it to now fund restart activities to launch gold production at its Beacon Gold Mill, first aiming to process the 10,000-20,000 metric tons ("mt") of mineralized stockpiles remaining on site.

SuperCom Ltd. (NASDAQ: SPCB) is a global provider of secure solutions spanning electronic monitoring, e-Government, and cybersecurity markets. Since 1988, the company has supported national governments and public agencies with advanced safety, identity, and tracking technologies. Its solutions enable courts, service providers, and public safety agencies to efficiently supervise high-risk populations, improve victims’ safety and manage compliance with judicial mandates across multiple jurisdictions.

SuperCom’s growth in North America has accelerated since mid-2024, with expansion into 11 new U.S. states and more than 30 contracts secured with public safety agencies and regional service providers, displacing long-standing incumbents in the process. This expansion reflects the company’s emphasis on recurring revenue, technological differentiation, and close partnership with agencies seeking innovative, mobile-first alternatives to outdated systems.

SuperCom’s vision is to revolutionize the public safety sector through proprietary electronic monitoring technology, data intelligence, and flawless execution. Its offerings include GPS and RF-based monitoring, biometric ID verification, mobile law enforcement tools, and national-level e-ID platforms.

The company is headquartered in Tel Aviv, Israel.

Products

Electronic Monitoring and Public Safety

SuperCom’s operations are anchored by its proprietary PureSecurity suite, a unified offender monitoring platform combining GPS tracking, biometric verification, tamper detection, and advanced data analytics. Its PureOne™ one-piece bracelet and PureTrack™ smartphone-integrated solution offer high-precision location tracking, real-time alerts, and seamless integration with PureCom™ base stations, PureBeacon™ indoor trackers, and PureProtect™, an app designed to safeguard domestic violence victims.

The company complements its hardware with PureMonitor™, a secure, cloud-based case management system that enables real-time oversight, mobile access, and data visualization for monitoring agencies. This full-stack approach allows SuperCom to support a range of court-mandated programs including GPS monitoring, house arrest, curfew enforcement, and community supervision. The company’s domestic violence monitoring solutions are now deployed in at least seven countries.

SuperCom’s U.S. subsidiary, Leaders in Community Alternatives (LCA), provides reentry and rehabilitation services that complement the company’s electronic monitoring programs. Operating primarily in California, LCA delivers community-based solutions designed to reduce recidivism and promote successful reintegration. Its programs include individualized case management, employment support, evidence-based treatment, and day reporting centers—services that support public safety while offering alternatives to incarceration. Since LCA’s acquisition in 2016, SuperCom secured over $35 million in new contract wins in Northern California.

Cybersecurity

SuperCom also offers additional capabilities through its cybersecurity and e-Government product lines. The company’s cybersecurity subsidiary, Safend Ltd., provides endpoint data protection through its Data Protection Suite. This platform includes modules for encryption (Encryptor), port/device control (Protector), data classification (Discoverer), DLP (Inspector), audit tracking (Auditor), and compliance reporting (Reporter).

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments and national agencies design and issue secured multi-identification documents and robust digital identity solutions to their citizens, visitors, and lands. The company has focused on expanding its activities, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

SuperCom operates across multiple high-growth sectors. In electronic monitoring, rising incarceration costs, overcrowded prisons, and increased judicial adoption of alternatives to detention continue to drive demand for GPS and RF-based supervision programs. The company’s rapid expansion into 11 U.S. states and multiple national-level deployments in Europe and the EMEA region reflect a robust and growing market. According to Mordor Intelligence, the electronic offender monitoring solutions market size stands at $2.18 billion in 2025 and is projected to reach $3.19 billion by 2030.

SuperCom also addresses two important supplementary markets through its cybersecurity and e-Government offerings. In cybersecurity, growing threats to sensitive government and enterprise data are fueling investments in endpoint protection, compliance, and device control, which are areas directly served by the company’s Safend platform. In the public sector identity space, secure ID, biometric verification, and e-passport programs remain foundational to digital governance. SuperCom’s track record of delivering national ID solutions across Africa, Latin America, and Eastern Europe underscores its continued relevance in these adjacent sectors.

Leadership Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Investment Considerations
  • SuperCom reported record net income of $5.3 million and non-GAAP EPS of $1.84 in the first half of 2025, reflecting strong financial performance.
  • The company has expanded into 11 new U.S. states since mid-2024, securing over 30 new electronic monitoring contracts and forming nine new provider partnerships.
  • Its recurring revenue model ensures consistent monthly billing based on unit count, promoting financial stability and predictability.
  • SuperCom operates across multiple high-growth sectors including public safety, national identity, and cybersecurity, offering diversified market exposure.
  • The company has a demonstrated ability to displace long-term incumbents and rapidly scale its solutions across new geographies.

SuperCom Ltd. (NASDAQ: SPCB), closed Wednesday's trading session at $8.48, off by 2.4166%, on 121,454 volume. The average volume for the last 3 months is 53,163 and the stock's 52-week low/high is $5.06/$18.95.

Recent News

Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)

The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).

BlockQuarry (OTC: BLQC) , a leading innovator in American-manufactured cryptocurrency mining solutions and sustainable energy infrastructure, announced it is now accepting preorders for its BLQCBuster(TM) crypto mining machines, a high-performance, enterprise-grade system engineered and manufactured in the United States. Housed in a robust 2U rack-mountable enclosure, the BLQCBuster features eight advanced hashboards powered by Intel Blockscale(TM) ASIC chips, delivering high hashrate performance with industry-leading power efficiency, and is designed to serve both individual miners and large-scale operations with no minimum preorder requirement.

To view the full press release, visit https://ibn.fm/zG3Kb

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.

The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.

The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.

PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.

The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.

Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.

Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.

Waterberg Project

Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.

The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.

The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.

South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.

Market Opportunity

According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.

Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.

A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.

Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.

An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.

Management Team

Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.

Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.

Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.

Platinum Group Metals Ltd. (NYSE American: PLG), closed Wednesday's trading session at $2.59, off by 2.2642%, on 4,967,476 volume. The average volume for the last 3 months is 4,107,817 and the stock's 52-week low/high is $0.99/$3.36.

Recent News

Safe and Green Holdings Corp. (NASDAQ: SGBX)

The QualityStocks Daily Newsletter would like to spotlight Safe and Green Holdings Corp. (NASDAQ: SGBX).

Safe and Green Holdings Corp. (NASDAQ: SGBX) is a diversified holding company focused on delivering innovative solutions across infrastructure, construction, energy, healthcare, and environmental sectors. Originally established in 2007 as SG Blocks, the company has evolved into a vertically integrated platform serving both public and private sector clients with modular, sustainable systems. Its operations span a range of industries unified by a commitment to efficient, scalable design and sustainability-driven development.

The company’s model centers on the production and deployment of prefabricated modular structures, energy systems, and infrastructure technologies, leveraging vertical integration and cross-sector synergies to support government agencies, medical networks, developers, and commercial enterprises. Safe and Green’s subsidiaries operate collaboratively to generate multiple revenue streams while pursuing opportunities in both traditional and next-generation infrastructure.

Safe and Green Holdings Corp. is headquartered in Miami, Florida.

Portfolio

SG Echo Manufacturing

SG Echo is the modular manufacturing arm of Safe and Green Holdings Corp., delivering prefabricated structures built from steel, wood, and repurposed shipping containers. As a Made-in-America manufacturer, SG Echo combines industry-leading machinery and skilled labor to execute modular projects for clients across the U.S. and globally. The company holds an ESR certification from the International Code Council for repurposed containers, enabling faster approvals and widespread applicability in commercial and industrial construction.

With the ability to reduce construction time by up to 50% and cut costs by 10–20%, SG Echo’s manufacturing process emphasizes speed, sustainability, and resilience. In October 2025, SG Echo’s operations were consolidated into a new facility in Conroe, Texas, where they now operate alongside Olenox Corp., a Safe and Green subsidiary focused on oil and gas operations, to streamline logistics and integrate manufacturing with field operations. Revenue is also generated through third-party property leasing at the Conroe site.

SG Modular Medical

SG Modular Medical designs and deploys modular point-of-care solutions tailored for the evolving demands of healthcare infrastructure. The system enables clinics and labs to be rapidly assembled from clinical, administrative, and diagnostic modules, offering adaptability based on local needs and population shifts. This modular approach is positioned as a lower-emission alternative to traditional medical construction, helping reduce the substantial carbon footprint associated with healthcare infrastructure.

Notable deployments include COVID-19 testing pods at Los Angeles International Airport (LAX), designed and delivered in partnership with airport authorities. Another initiative, launched with The Peoples Healthcare and Teamsters Local 848, involves delivering modular clinics to serve union members with onsite, high-quality care staffed by a top-tier clinical operator.

SG Development Corp.

SG DevCorp is the real estate development division of Safe and Green Holdings Corp., focused on building modular single- and multifamily projects across various income levels. The company pursues strong, green developments supported by vertically integrated manufacturing from SG Echo. SG DevCorp has stated development targets of more than 4,000 modular units totaling over 3.2 million square feet across 1,000+ acres of acquired land—a construction pipeline valued at approximately $765 million.

The division prioritizes sustainability throughout the lifecycle of its developments, reducing construction waste, energy usage, emissions, and noise pollution. Its projects aim to minimize the environmental impact while enhancing speed-to-market and structural resilience.

SG Environmental Solutions

SG Environmental Solutions provides modular environmental infrastructure and sustainable waste management technologies. At the core of this division is Sanitec, a patented system designed for medical waste sterilization and volume reduction. The technology helps organizations reduce their environmental impact while significantly lowering operational costs.

The company emphasizes responsible construction and stewardship through upcycling, waste reduction, and adaptable modular deployments. Its container-based platforms are built for diverse use cases across commercial, residential, industrial, and environmental applications, with a focus on high-efficiency, reduced-emission outcomes.

Olenox Energy

Olenox Energy is the energy development arm of Safe and Green Holdings, focused on acquiring and revitalizing distressed oil and gas assets. In May 2025, the company acquired 1,600 acres of wells and leases from Sherman Oil & Gas and its affiliates, adding 111 wells to the Olenox portfolio. Since the acquisition, Olenox has produced over 3,000 barrels of oil and is currently achieving peak production rates of 55 barrels per day. The company is preparing additional workovers to add 25–30 bpd and has completed full asset mobilization into Texas. Olenox also holds a 51% stake in Winchester Oil & Gas, representing more than 500 wells across the state.

The company is executing its strategy to build a fully integrated oil and gas platform. Olenox operations remain in full compliance with the Texas Railroad Commission, with a stated emphasis on environmental stewardship and reduced lease operating expenses.

In September 2025, Safe and Green entered into an Open Collaborative Framework with OneQode, a global digital infrastructure company. The agreement supports joint development of spill detection, real-time telemetry, and command systems for remote energy assets, enhancing Olenox’s operational capabilities through automation and data infrastructure.

Market Opportunity

Safe and Green Holdings is positioned to capitalize on macro trends across multiple sectors. The construction and real estate industries continue to seek faster, greener alternatives to traditional building methods—needs that SG Echo and SG DevCorp address through prefabricated, modular designs. In healthcare, rising demand for scalable care infrastructure underscores the relevance of SG Modular Medical’s point-of-care solutions.

Within energy, Olenox targets long-term value in revitalizing overlooked oil and gas assets. Its operational model, combined with emerging infrastructure technology partnerships, aims to improve field performance while maintaining environmental compliance. Through this diversification, Safe and Green aligns its platform with infrastructure modernization, energy resilience, and sustainability imperatives.

Leadership Team

Michael McLaren, Chairman and Chief Executive Officer, brings over 30 years of leadership in the energy industry, including military and field service projects, mergers and acquisitions, and technology development. He is the founder of Olenox Ltd., a developer of proprietary energy systems, and holds advanced degrees in Science and Business from the University of British Columbia. McLaren has authored multiple papers on alternative fuels and energy systems and serves as a lead strategist for Safe and Green’s cross-sector growth.

Patricia Kaelin, CPA, Chief Financial Officer, has more than 30 years of experience in public company financial management, mergers and acquisitions, and strategic capital deployment. She previously served as CFO and CIO of a billion-dollar construction company overseeing operations across 14 states. Her background spans construction, healthcare, manufacturing, and real estate. Kaelin holds a bachelor’s degree in business administration with a concentration in accounting from California State University, Fullerton.

Jim Pendergast, Chief Operating Officer, has held executive leadership roles across multiple sectors, including energy, construction, and agriculture. He has served as COO, CFO, and CEO at public and private firms, overseeing operations, acquisitions, and project execution. He holds an MBA in international business and finance from McMaster University and a BA in political studies and economics from Queen’s University.

Investment Considerations
  • Safe and Green operates a vertically integrated business across modular construction, environmental solutions, healthcare, and energy.
  • SG Echo’s relocation and consolidation into a new Texas facility supports streamlined manufacturing and operational synergy with Olenox Energy.
  • Olenox has delivered strong early production results and continues to expand its U.S. energy footprint through strategic acquisitions and field revitalization.
  • SG Modular Medical has deployed real-world installations at major public sites such as LAX and is working with nonprofit and labor organizations on scalable healthcare delivery.
  • The company’s environmental division leverages proprietary Sanitec technology to provide sustainable, cost-reducing solutions for medical waste management.

Safe and Green Holdings Corp. (NASDAQ: SGBX), closed Wednesday's trading session at $1.93, off by 5.8537%, on 646,976 volume. The average volume for the last 3 months is 1,547,881 and the stock's 52-week low/high is $1.81/$122.88.

Recent News

Wearable Devices Ltd. (NASDAQ: WLDS)

The QualityStocks Daily Newsletter would like to spotlight Wearable Devices Ltd. (NASDAQ: WLDS).

Wearable Devices Ltd. (NASDAQ: WLDS) is a growth-stage technology company pioneering the next generation of human-computer interaction through AI-powered neural input wearables. Mudra, its proprietary wrist-worn technology, enables touchless, gesture-based control of digital devices, offering users a seamless, intuitive interface through subtle finger and hand movements. Since introducing its technology to the market in 2014, the company has pursued both business-to-business (B2B) and business-to-consumer (B2C) strategies through a dual-channel model.

The company believes the future of technology should begin with the human. Wearable Devices envisions decoding the human body to enable context-aware AI-powered technology that listens, learns, and adapts – to us.

The company envisions a future where human intent becomes the language of technology. Through non-invasive neural sensing and adaptive algorithms, the company enables more natural, personalized, and intuitive interactions with computers.

The company is headquartered in Yokneam Illit, Israel.

Products

Neural control has entered the market: commercially available since 2023 with the Mudra Band and already used by thousands of users worldwide. With its product line, including Mudra Band and Mudra Link, the company has introduced the world’s first wrist-worn neural interfaces, enabling intuitive, touchless control through natural micro-gestures: subtle finger movements and wrist flicks. Whether streaming media, controlling smart devices, or interacting with AR glasses, Mudra brings neural input into everyday life.

This early adoption isn’t just validation — it’s acceleration. With real users engaging in real environments, the company is learning fast, improving faster, and shaping a product that grows more refined with every interaction.

Mudra Band

Mudra Band is the company’s flagship B2C product, designed as a sleek, aftermarket accessory for the Apple Watch. It uses patented sEMG sensors to detect neural signals from the wrist and translates them into real-time digital commands. This allows users to control and streamline interactions between the iPhone, iPad, MacBook, and Apple TV using familiar micro-gestures like taps, pinches, or swipes — all without touching a screen.

The device features a high-resolution analog front end, IMU integration, adaptive machine learning, and ergonomic form factors for all-day comfort. Users can toggle between multiple Apple devices using the Mudra Band’s dedicated Apple Watch face, enabling a fully connected, touchless experience. The Mudra Band is optimized for low-latency, high-accuracy interactions and supports a wide range of digital applications. The Mudra Band received a CES 2021 Innovation Award.

Mudra Link

Mudra Link expands the company’s reach beyond the Apple ecosystem, offering compatibility with Android, Windows, and AR/XR platforms. The product includes the innovative Gesture Mapper feature, allowing users to assign personalized commands to gestures such as tap, pinch, flick, or twist. This functionality replaces or augments traditional input methods, supporting media controls, pointer input, and full directional mapping. A key feature of Mudra Link is its dual-mode input system (mouse mode or D-pad mode), empowering users to personalize control schemes across devices, operating systems, and user interfaces.

Mudra Link is recognized for its ergonomic design, lightweight build, and plug-and-play ease of use. It supports native integration with AR glasses from leading manufacturers and received a CES 2025 Innovation Award.

Mudra DevKit and Integration

In parallel with its consumer devices, Wearable Devices offers a Mudra Developer Kit (MDK) and integration program for enterprise and OEM partners. The MDK includes full-stack tools (hardware bands, SDK, APIs, and sample code) that allow developers and original equipment manufacturers to embed Mudra’s neural sensing capabilities into their own products and applications. For example, an AR headset maker can integrate Mudra’s sensors to enable native hand-gesture input, or a software developer can use Mudra’s API to track user gestures for novel interactions.

The MDK supports both Android and iOS and even provides real-time neural raw signal monitoring for research and prototyping. This B2B offering not only expands Mudra technology into new environments such as industrial automation, robotics, and gaming peripherals, but also fosters a broader ecosystem of Mudra-powered solutions. By lowering the barrier for others to adopt its AI gesture recognition engine, Wearable Devices accelerates innovation and garners strategic relationships.

The MDK and related licensing offerings illustrate Wearable Devices’ push-pull strategy: selling consumer products today, while seeding ‘Mudra inside’ into other companies’ devices tomorrow.

Market Opportunity & Strategy

Wearable Devices operates at the intersection of neural interfaces, wearable computing, and the rapidly expanding AR/XR sector. According to MarketsandMarkets, the global AR and VR market is projected to grow from $22.12 billion in 2024 to $96.32 billion by 2029, at a CAGR of 34.2%. The rising demand for natural, hands-free input methods positions neural wearables like Mudra as foundational components in spatial computing and smart environments.

Additionally, the health monitoring wearables market is gaining traction as neural biosignals become a promising data source. The company’s LMM (Large Motor Unit Action Potential Model) platform is being explored for predictive health monitoring, cognitive state tracking, and performance analytics. Government-level support, such as advocacy from the U.S. Secretary of Health and Human Services, further validates the sector’s momentum.

Combined with patent-protected technology and strategic alliances with companies like Qualcomm, TCL-RayNeo™, and Media Exceed, Wearable Devices is well-positioned to capture value across consumer, enterprise, and healthcare verticals.

The company’s phased market strategy anticipates this:

  • Phase 1 – Enthusiast Consumer Adoption: Introduce Mudra Band as an add-on for Apple Watch (tapping into a passionate user base of early adopters and tech enthusiasts). Achieve proof-of-concept and get market feedback. This phase built brand credibility and seeded a community of users.
  • Phase 2 – Expand Platform & Ecosystem: Launch Mudra Link for all users and open the Mudra SDK to developers and B2B partners. Focus on the XR/AR market and tech-savvy consumers, while enabling enterprise use-cases through the Developer Kit and strategic partnerships. The company is actively showcasing its tech to industry leaders and integrating with their platforms.
  • Phase 3 – Leverage Data & Enter New Verticals: With a growing user base, Wearable Devices is collecting an invaluable dataset of neural signals and usage patterns. If data is the new oil for AI, neural signals will power the next computing revolution — enabling machines to understand human intent in real time. This fuels its Large Motor-Unit Action Potential Model (LMM) – a bio-signal intelligence platform that continuously learns from neural data to improve accuracy and enable new applications. One major new vertical is digital health and wellness: Wearable Devices is adapting its tech to track physiological and cognitive indicators from the wrist. Because the Mudra sensors capture muscle activation signals, they can potentially detect patterns related to stress, fatigue, focus, and even early signs of health conditions before traditional symptoms appear, and Wearable Devices recently announced it is expanding LMM into predictive health monitoring and cognitive analytics. This means the company could offer solutions for workplace productivity (measuring alertness), athletic training (muscle fatigue analytics), or preventive healthcare (flagging neuromuscular irregularities) – vastly broadening its addressable market. Through monitor applications, the vision is to go from controlling devices to also understanding the user, providing actionable bio-insights. The LMM platform’s AI continuously adapts to each individual’s neural profile, enabling truly personalized and proactive applications.
  • Phase 4 – Ubiquitous Adoption via B2B Integration: Finally, Wearable Devices plans to drive mass adoption by aligning with major consumer tech players. By making its Mudra Data Platform available to enterprises, OEMs, and app developers, the company positions itself as the backbone for neural interaction services. By “laying the groundwork for the next neural frontier”, Wearable Devices is ensuring that when the tech giants move to adopt neural input, its platform is the mature, data-rich standard ready to be deployed.

Through these phased efforts, Wearable Devices balances B2C and B2B paths. It generates near-term revenues and user feedback via direct consumer product sales, while simultaneously developing long-term enterprise relationships and intellectual property value. This dual model not only diversifies revenue streams but also reinforces the technology’s credibility: consumer adoption demonstrates demand and usability, which in turn attracts enterprise interest, creating a virtuous cycle.

Leadership Team

Asher Dahan, Chief Executive Officer, co-founded Wearable Devices Ltd. in 2014 and has served as CEO and director since 2016. He is a seasoned executive with proven expertise in strategic planning, project execution, and business leadership. Asher oversees the company’s operations and resources, guiding major corporate decisions and long-term vision. Prior to founding Wearable Devices, he held engineering and leadership roles at Intel Haifa, specializing in high-speed interface validation. He holds a BSc in Electrical Engineering from Ort Braude College.

Guy Wagner, Chief Scientific Officer and President, co-founded Wearable Devices Ltd. in 2014 and has served on its board since inception. As CSO and President, Guy leads the company’s technological innovation and scientific direction. He is the main inventor behind the company’s core technology and brings multidisciplinary expertise in hardware design, biomedical signal processing, embedded programming, and sensor systems. He previously worked at Intel as a hardware engineer and holds a BSc in Electrical Engineering from Ort Braude College.

Leeor Langer, co-founder and CTO since 2016, is a leading expert in algorithms, machine learning, and signal and image processing. He has held senior R&D roles in the medical imaging and digital security sectors, including at Intel, and brings deep academic and industry experience. Leeor has authored several scientific papers and holds a BSc from the Technion and an MSc in Applied Mathematics from Tel Aviv University, graduating cum laude.

Investment Considerations
  • Wearable Devices holds a first-mover advantage in AI-powered neural input wearables, with validation from CES Innovation Awards and early adoption in key markets.
  • The company operates a dual-channel strategy that targets both consumer product sales and enterprise licensing opportunities.
  • Strategic partnerships with Qualcomm, TCL-RayNeo™, and Media Exceed support the company’s efforts to scale commercialization globally.
  • Its expanding patent portfolio includes recent U.S. approvals for gesture-based and hybrid voice control technologies, reinforcing its competitive edge.
  • With active initiatives in XR, spatial computing, and predictive health monitoring, the company is positioned to benefit from multiple high-growth sectors.

Wearable Devices Ltd. (NASDAQ: WLDS), closed Wednesday's trading session at $1.22, off by 11.5942%, on 756,123 volume. The average volume for the last 3 months is 730,388 and the stock's 52-week low/high is $1/$11.3999.

Recent News

Datavault AI Inc. (NASDAQ: DVLT)

The QualityStocks Daily Newsletter would like to spotlight Datavault AI Inc. (NASDAQ: DVLT).

Datavault AI Inc. (NASDAQ: DVLT) is a pioneering leader in immersive, wireless sound technology, providing cutting-edge audio solutions for intelligent devices and next-generation home entertainment systems. The company collaborates with top consumer electronics (CE) brands and manufacturers, including industry giants like Harman International (a division of Samsung), LG, Hisense, TCL, Bang & Olufsen, and Platin Audio. WiSA Technologies delivers exceptional wireless sound experiences for high-definition content, including movies, music, sports, gaming, and esports, thereby enhancing the overall consumer experience in home entertainment.

As a founding member of WiSA™ (the Wireless Speaker and Audio Association), WiSA Technologies plays a critical role in defining wireless audio interoperability standards, ensuring seamless integration across devices and platforms. The company actively works with leading consumer electronics companies, technology providers, retailers, and ecosystem partners to promote and market spatial audio technologies, underscoring its commitment to advancing the future of audio and making high-quality, immersive sound accessible to a broader audience.

Headquartered in Beaverton, Oregon, WiSA Technologies extends its global reach with sales teams strategically located in Taiwan, China, Japan, Korea, and California. This international presence allows the company to effectively serve a diverse customer base and maintain strong relationships with key partners worldwide. By continuously innovating and setting new benchmarks in wireless audio, WiSA Technologies is well-positioned to remain at the forefront of the evolving home entertainment landscape.

The WiSA Association

The WiSA® Association, a wholly owned subsidiary of WiSA Technologies, is dedicated to promoting and standardizing spatial audio solutions for home entertainment, ensuring that immersive audio experiences are accessible to everyone. In collaboration with leading consumer electronics companies, technology providers, retailers, and ecosystem partners, the association works to advance wireless audio technology across various devices, making high-quality sound an integral part of modern home entertainment systems. As a key player in the industry, WiSA LLC, also known as the Wireless Speaker and Audio Association, is instrumental in fostering the adoption and integration of cutting-edge audio technologies.

Recently, the WiSA Association significantly expanded its influence by executing licensing agreements with leading HDTV brands, covering 43% of the HDTV market that uses the Android operating system, the most widely used OS in the market. By focusing on Android-based HDTVs and collaborating with speaker manufacturers, WiSA is actively building an ecosystem of WiSA E-enabled speaker systems, mirroring the success of its earlier WiSA HT technology. This strategic initiative, combined with WiSA E’s compatibility with multiple HDTV SoC providers and support for spatial audio formats like Dolby Atmos FlexConnect, positions the association at the forefront of transforming home audio experiences, driving widespread adoption across the home entertainment landscape.

Market Opportunity

From an investment perspective, WiSA Technologies Inc. is strategically positioned to capitalize on the growing demand for wireless and immersive audio experiences as consumer preferences shift toward high-definition home entertainment systems. As streaming services, gaming, and smart home technologies continue to expand, the need for seamless, high-quality audio solutions is becoming increasingly critical. WiSA Technologies, with its innovative wireless sound technology and strong partnerships with leading consumer electronics brands, is well-placed to capture a significant share of this expanding market, particularly as more consumers seek to enhance their home entertainment experiences.

Moreover, the company’s focus on setting industry standards through the WiSA Association further solidifies its role as a key player in the evolving audio landscape. By driving the adoption of wireless audio interoperability standards, WiSA Technologies not only ensures broad compatibility across devices but also positions itself as a leader in the market, capable of influencing future trends and technologies. This proactive approach, combined with its established global presence and collaborations with top-tier brands, provides WiSA Technologies with a strong foundation for sustained growth, making it an attractive opportunity for investors looking to gain exposure to the burgeoning home entertainment and smart audio sectors.

Leadership Team

Brett Moyer is the Chief Executive Officer, President, and Chairman of WiSA Technologies, Inc., and a founding member of the company. He has served in these leadership roles since August 2010. Prior to this, Mr. Moyer was the president and CEO of Focus Enhancements, Inc., where he oversaw the development and marketing of proprietary video technology. He has a rich background in consumer electronics, having held key positions at Zenith Electronics Inc., including Vice President and General Manager of its Commercial Products Division. Mr. Moyer also serves on the board of directors of Alliant International University and has previously served on the boards of HotChalk, Inc., and NeoMagic Corporation. He holds a Bachelor of Arts in Economics from Beloit College and an MBA in Finance and Accounting from Thunderbird School of Global Management.

Gary Williams is the Chief Accounting Officer and Vice President of Finance at WiSA Technologies, Inc., roles he has held since September 2019 and the company’s founding in August 2010, respectively. He previously served as the company’s Chief Financial Officer and Secretary until 2019. Mr. Williams has extensive experience in finance, having served as CFO of Quantum3D, Inc., and in similar roles at Focus Enhancements Inc. and Videonics Inc. He began his career in public accounting with Coopers & Lybrand LLP. Mr. Williams is a certified public accountant (inactive) and holds a bachelor’s degree in business administration with an emphasis in accounting from San Diego State University.

Investment Considerations
  • WiSA Technologies is strategically positioned in the rapidly growing market for wireless and immersive audio solutions, with strong partnerships with leading consumer electronics brands like Samsung, LG, and Bang & Olufsen.
  • The company’s proprietary WiSA E technology is driving innovation in home entertainment, offering a scalable platform that supports advanced audio formats such as Dolby Atmos and DTS:X.
  • WiSA Technologies’ recent licensing agreements with major HDTV brands covering 43% of the Android OS market significantly expand its market reach and revenue potential.
  • Led by an experienced management team with deep industry knowledge, WiSA Technologies is well-equipped to capitalize on the increasing demand for high-quality, wireless audio experiences.
  • With a focus on setting industry standards through the WiSA Association, the company is positioned as a leader in the evolving audio technology landscape, providing a strong foundation for long-term growth.
Additional Resources

Datavault AI Inc. (NASDAQ: DVLT), closed Wednesday's trading session at $1.155, off by 17.5%, on 95,154,457 volume. The average volume for the last 3 months is 80,939,213 and the stock's 52-week low/high is $0.2512/$4.1.

Recent News

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF)

The QualityStocks Daily Newsletter would like to spotlight SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF).

SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) develops next-generation, GPS-free target acquisition system and autonomous navigation software for drones and edge devices. Its zero-signature technology delivers real-time detection, tracking, and behavioral insights without reliance on radar, lidar, or heavy sensors. The company’s platform transforms unmanned systems into autonomous tools capable of identifying and engaging targets in GPS-denied environments.

The company’s vision is to redefine situational awareness by merging advanced mathematics, AI modeling, and edge computing into a unified intelligence architecture. SPARC AI aims to empower defense, rescue, and commercial organizations to operate safely and effectively in signal-contested environments where traditional navigation systems fail.

Its mission is to build the world’s most trusted geolocation intelligence platform that operates without GPS, enabling seamless interoperability across air, land, and sea devices.

SPARC AI is headquartered in Toronto, Canada.

Technology

SPARC AI’s technology suite delivers precision target acquisition, navigation, and autonomous intelligence in environments where GPS and traditional sensors fail. At its core is the Target Acquisition System, a software-only solution that determines the geolocation of any visible object using camera telemetry data. By removing the need for specialized hardware like lasers, radar, or lidar, the platform reduces weight, power use, and cost. Built on advanced mathematical modeling, it constructs a 3D understanding of terrain and position, achieving GPS-level accuracy in a zero-signature configuration suited for defense, rescue, and commercial operations.

SPARC AI Mobile extends this capability to handheld and field-issued devices, allowing operators to mark and transmit target coordinates directly from smartphones or rugged tablets. Once a target is identified, the device relays the coordinates to a connected drone, which autonomously navigates to the location for reconnaissance or engagement. The mobile system maintains accuracy even in GPS-jammed or degraded environments, turning each device into a connected node within a broader distributed network.

The company’s GPS-Denied Navigation engine enables mission planning and execution without satellite signals. Operators can design flight paths, define perimeters, and simulate routes to identify optimal vantage points and minimize resource use. Counter-surveillance and threat-prediction tools model adversarial visibility, helping users avoid detection and maximize ground coverage. Together, these capabilities form the foundation of SPARC AI’s software architecture, providing the intelligence backbone for its integrated command platform.

Overwatch Target Intelligence

Overwatch unifies all SPARC AI technologies, including its Target Acquisition, Mobile, and Navigation systems, into a single mission-ready platform that fuses detection, classification, tracking, and navigation in real time. It transforms drones and robotic systems into fully autonomous intelligence assets by synchronizing data across connected devices. The platform’s zero-signature design ensures complete operational security, allowing defense and rescue teams to conduct surveillance, reconnaissance, and engagement without GPS or active sensors.

Within Overwatch, the ATLAS Visibility Intelligence Engine enhances mission planning and reconnaissance through 2D and 3D visualization. Users can simulate line-of-sight coverage from any altitude, identify unseen or occluded areas, and optimize routes for surveillance or search and rescue. Operating entirely through software, ATLAS produces high-fidelity visibility data without mapping drones or additional power consumption, providing a lightweight, silent, and sensor-free alternative to lidar-based systems.

The SPARC AI SDK and open API framework extend Overwatch’s interoperability. Developers can embed SPARC AI’s intelligence into third-party systems such as PX4- and ArduPilot-powered drones, the world’s most widely used open-source flight platforms. The SDK provides REST APIs with bindings for Python, C++, and JavaScript and supports hardware including NVIDIA Jetson, Qualcomm Robotics RB5, and Raspberry Pi. Through these integrations, Overwatch serves as the command and intelligence layer of SPARC AI’s ecosystem, linking distributed drones, sensors, and edge devices into a coordinated autonomous network that operates entirely without GPS.

Market Opportunity

SPARC AI operates within the rapidly expanding defense, security, and commercial drone markets projected to exceed $100 billion over the next decade. The company’s software-defined approach addresses the global demand for autonomous systems capable of performing in denied, degraded, intermittent, and limited (DDIL) environments, positioning SPARC AI at the forefront of next-generation geolocation and targeting solutions.

Fortune Business Insights projects the global commercial drone market will reach approximately $65.25 billion by 2032, while Grand View Research estimates the combined drone hardware and services market will grow to $163.6 billion by 2030. With its per-device subscription model and integration across drones and robotic systems, SPARC AI is structured to capture recurring revenue from this accelerating adoption of GPS-denied intelligence technologies.

Leadership Team

Anoosh Manzoori, CEO, brings extensive experience as a technology entrepreneur, investor, and director, having founded, scaled, and exited multiple high-tech companies. He has taken five companies public, served on seven public company boards, and invested in innovations spanning cloud, fintech, biotech, IoT, defense, and AI.

Justin Hanka, Director, is an investment banking professional with 25 years of experience in mergers and acquisitions and capital markets. He has held executive roles at high-growth companies including iSelect.com.au and Helpmechoose, achieving multiple successful exits.

Anthony Haberfield, Director, is an international financial services executive with 30 years of experience across the Asia Pacific region, specializing in strategy, transformation, procurement, and emerging technology.

Investment Considerations
  • SPARC AI has completed 15 years of research and development, resulting in registered patents and a proprietary zero-signature GPS-denied technology platform.
  • The company has launched the Overwatch platform and expanded its technology suite through integrated modules including ATLAS and SPARC AI Mobile, broadening its applications across defense, rescue, and commercial operations.
  • A Preferred Reseller Agreement with Precision Technic Defence Group strengthens SPARC AI’s global distribution across Australia, Europe, and the United States.
  • Integration with QGroundControl connects SPARC AI’s Overwatch platform to millions of drones powered by PX4 and ArduPilot.
  • SPARC AI’s scalable software-as-a-service model and defense partnerships position the company for long-term growth in autonomous intelligence systems.

SPARC AI Inc. (OTCQB: SPAIF), closed Wednesday's trading session at $0.56, off by 6.6667%, on 63,610 volume. The average volume for the last 3 months is 62,860 and the stock's 52-week low/high is $0.0715/$1.3.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) s a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America. Originally founded in 2006 as a mineral exploration company, Ucore has since evolved into a processing technology innovator focused on commercializing its proprietary RapidSX™ platform under a $18.4 million contract from the U.S. Department of Defense, with additional support from Natural Resources Canada. The company’s flagship deployment is the Louisiana Strategic Metals Complex (“SMC”), with additional SMCs planned to follow.

Ucore’s mission is to help reestablish a domestic REE supply chain by offering competitive, modular processing solutions that reduce dependence on China. Supported by government funding, private capital, and engineering partnerships, Ucore aims to meet growing demand for rare earth oxides in electric vehicles, defense systems, and advanced energy technologies.

The company is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Separation Technology

RapidSX™ is Ucore’s proprietary rare earth separation platform, delivering three times faster processing than traditional solvent extraction (SX) methods. Its current demonstration program in Kingston, Ontario, is being conducted under contract with the U.S. Department of Defense to prove commercial readiness for processing both heavy and light REEs. The project is also supported by Natural Resources Canada.

RapidSX™ employs a column-based design that eliminates the need for powered mixer-settlers, enabling a smaller facility footprint, quicker commissioning, and lower CAPEX and OPEX. The platform is adaptable to light and heavy REE feedstocks and is structured for modular scale-up.

The 52-stage RapidSX™ Commercial Demonstration Plant in Kingston, Ontario—operated in partnership with Kingston Process Metallurgy—has logged thousands of runtime hours and is currently processing rare earth feedstock further to the company’s U.S. Department of Defense contract. In January 2025, Ucore secured a $500,000 non-dilutive grant from Ontario’s Critical Minerals Innovation Fund to support the advancement of the Kingston facility and, in the words of Ontario Mines Minister George Pirie, “build a secure supply chain ready to fuel the technologies of tomorrow.”

Strategic Metals Complex – Louisiana

Ucore has selected an 80,800-square-foot brownfield site within the England Airpark in Alexandria, Louisiana, as the location for its first commercial rare earth refining facility. The Louisiana SMC is expected to scale from 2,000 tonnes per annum (TPA) of total rare earth oxides initially to 5,000 TPA, with potential to ultimately reach 7,500 TPA.

The facility benefits from Foreign Trade Zone (FTZ) status, reducing tariff burdens on imported inputs and enhancing logistics efficiency. In addition to these structural advantages, the state of Louisiana has outlined an incentive package valued at $15 million, including a $900,000 infrastructure grant and $360,000 in additional local support. The project is expected to create 100 family-wage jobs and has received strong support from federal and state officials.

To date, Ucore has secured $2.3 million in milestone payments under its $18.4 million OTA award from the U.S. Department of Defense. In early 2024, the company also secured C$2.16 million in private investment from Hondo Private Equity to support its commercialization efforts.

Bokan-Dotson Ridge REE Project – Alaska

Ucore maintains 100% ownership of the Bokan-Dotson Ridge heavy REE project in Southeast Alaska. A Preliminary Economic Assessment was completed in January 2013. The Alaska Industrial Development and Export Authority (AIDEA) has authorized $145 million in bond financing under SB99 (2014) to support future development.

While Bokan remains a long-term asset, Ucore continues to advance it at a measured pace, complementing its near-term focus on commercial rare earth refining and oxide production at the Louisiana SMC.

Market Opportunity

According to Grand View Research, the global rare earth elements market was estimated at $3.95 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. The market outlook remains strong, fueled by the growing demand for permanent magnets and catalysts in the automotive sector.

In March 2025, President Trump invoked the Defense Production Act to prioritize domestic critical mineral production, signaling a national mandate to reduce reliance on “hostile foreign powers’ mineral production.” One month later, the Chinese government enacted immediate export restrictions on seven key rare earth elements, including dysprosium and terbium, further intensifying pressure on Western nations to develop secure and independent supply chains. This underscores the strategic value of Ucore’s domestic separation infrastructure.

Leadership Team

Pat Ryan, P.Eng., Chairman and CEO, is the founder of Neocon International, a leading automotive OEM supplier. He brings over 25 years of experience in global supply chain innovation and has led Ucore since 2014 in its strategic pivot toward rare earth processing.

Peter Manuel, Vice President, CFO & Corporate Secretary, has served as Ucore’s financial lead for 14 years. Trained as a Chartered Accountant, with extensive experience across Canada, England, and Ireland, Mr. Manuel has advised public and private entities on strategic planning, treasury, and assurance.

Michael Schrider, MEng, P.E., Vice President & COO, is a multidisciplinary engineer with over 30 years of experience. He founded and operated engineering firms SAi and ABD and has overseen all phases of Ucore’s technical development since 2016.

Geoff Atkins, Vice President of Business Development, has 30 years of mining experience and was instrumental in advancing both Lynas’ Mt. Weld and Vital Metals’ Nechalacho REE operations. He brings deep operational knowledge and leads feedstock strategy at Ucore.

Investment Considerations
  • The company is closely aligned with national policy, receiving funding from both the U.S. Department of Defense ($18.4 million) and Natural Resources Canada (C$4.3 million).
  • Ucore’s RapidSX™ platform promises to deliver faster REE separation than traditional SX and is being commercialized at scale.
  • The Louisiana SMC aims to ramp to 7,500 TPA rare earth oxide production and benefits from FTZ status, DoD funding, and private equity backing.
  • Ucore’s 100%-owned Bokan-Dotson Ridge project remains a potentially valuable strategic heavy REE resource supported by a $145M AIDEA bond.
  • As China imposes REE export restrictions and the U.S. escalates domestic production policy, Ucore is positioned as a secure Western alternative.

Ucore Rare Metals Inc. (OTCQX: UURAF), closed Wednesday's trading session at $5.24, up 24.7619%, on 1,550,636 volume. The average volume for the last 3 months is 526,740 and the stock's 52-week low/high is $0.4445/$10.69.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.